NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 26 filers reported holding NIVALIS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 225,000 | $3,409,000 | 3.46% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,732,412 | $56,546,000 | 1.88% |
| RA Capital Management | 757,263 | $11,473,000 | 1.15% |
| Rock Springs Capital Management LP | 564,358 | $8,550,000 | 0.62% |
| Monashee Investment Management LLC | 62,500 | $947,000 | 0.45% |
| SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $3,863,000 | 0.38% |
| WALL STREET ASSOCIATES | 192,400 | $2,915,000 | 0.28% |
| Ghost Tree Capital, LLC | 50,000 | $758,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 430,041 | $6,515,000 | 0.24% |
| Endurant Capital Management LP | 46,500 | $704,000 | 0.21% |